Berry Genomics Co Ltd (000710) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Berry Genomics Co Ltd (000710) has a cash flow conversion efficiency ratio of -0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-2.18 Million ≈ $-319.41K USD) by net assets (CN¥1.65 Billion ≈ $241.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Berry Genomics Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Berry Genomics Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Berry Genomics Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Berry Genomics Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Berry Genomics Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Turaco Gold Ltd
AU:TCG
|
-0.146x |
|
Ningbo David Medical Device Co Ltd
SHE:300314
|
0.118x |
|
Xin Hee Co Ltd
SHE:003016
|
0.007x |
|
Good Finance Securities Co Ltd
TWO:6021
|
-0.007x |
|
Citra Putra Realty Tbk PT
JK:CLAY
|
3.955x |
|
LF Corp
KO:093050
|
0.051x |
|
Shanghai Xujiahui Commercial Co Ltd
SHE:002561
|
0.021x |
|
Zhangjiagang Zhonghuan Hailu High-End Equipment Co. Ltd.
SHE:301040
|
N/A |
Annual Cash Flow Conversion Efficiency for Berry Genomics Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Berry Genomics Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see 000710 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.72 Billion ≈ $250.98 Million |
CN¥87.97 Million ≈ $12.87 Million |
0.051x | -12.46% |
| 2023-12-31 | CN¥1.89 Billion ≈ $277.24 Million |
CN¥111.01 Million ≈ $16.24 Million |
0.059x | +544.41% |
| 2022-12-31 | CN¥2.33 Billion ≈ $340.85 Million |
CN¥21.18 Million ≈ $3.10 Million |
0.009x | -75.60% |
| 2021-12-31 | CN¥2.52 Billion ≈ $369.30 Million |
CN¥94.03 Million ≈ $13.76 Million |
0.037x | -44.05% |
| 2020-12-31 | CN¥2.42 Billion ≈ $354.48 Million |
CN¥161.31 Million ≈ $23.60 Million |
0.067x | +27.01% |
| 2019-12-31 | CN¥2.35 Billion ≈ $343.45 Million |
CN¥123.06 Million ≈ $18.01 Million |
0.052x | -38.40% |
| 2018-12-31 | CN¥1.94 Billion ≈ $284.22 Million |
CN¥165.33 Million ≈ $24.19 Million |
0.085x | +78.65% |
| 2017-12-31 | CN¥1.56 Billion ≈ $228.34 Million |
CN¥74.35 Million ≈ $10.88 Million |
0.048x | +138.30% |
| 2016-12-31 | CN¥114.08 Million ≈ $16.69 Million |
CN¥-14.19 Million ≈ $-2.08 Million |
-0.124x | +79.32% |
| 2015-12-31 | CN¥117.69 Million ≈ $17.22 Million |
CN¥-70.81 Million ≈ $-10.36 Million |
-0.602x | -513.72% |
| 2014-12-31 | CN¥130.03 Million ≈ $19.03 Million |
CN¥18.91 Million ≈ $2.77 Million |
0.145x | +12.60% |
| 2013-12-31 | CN¥121.00 Million ≈ $17.71 Million |
CN¥15.63 Million ≈ $2.29 Million |
0.129x | -66.90% |
| 2012-12-31 | CN¥123.68 Million ≈ $18.10 Million |
CN¥48.27 Million ≈ $7.06 Million |
0.390x | +322.78% |
| 2011-12-31 | CN¥122.50 Million ≈ $17.93 Million |
CN¥-21.46 Million ≈ $-3.14 Million |
-0.175x | -128.10% |
| 2010-12-31 | CN¥122.22 Million ≈ $17.89 Million |
CN¥76.19 Million ≈ $11.15 Million |
0.623x | +3165.21% |
| 2009-12-31 | CN¥114.51 Million ≈ $16.76 Million |
CN¥-2.33 Million ≈ $-340.79K |
-0.020x | -103.67% |
| 2008-12-31 | CN¥104.34 Million ≈ $15.27 Million |
CN¥57.76 Million ≈ $8.45 Million |
0.554x | +1012.22% |
| 2007-12-31 | CN¥94.51 Million ≈ $13.83 Million |
CN¥4.70 Million ≈ $688.23K |
0.050x | -57.48% |
| 2006-12-31 | CN¥99.78 Million ≈ $14.60 Million |
CN¥11.68 Million ≈ $1.71 Million |
0.117x | +52.21% |
| 2005-12-31 | CN¥98.59 Million ≈ $14.43 Million |
CN¥7.58 Million ≈ $1.11 Million |
0.077x | +234.93% |
| 2004-12-31 | CN¥112.75 Million ≈ $16.50 Million |
CN¥-6.43 Million ≈ $-940.18K |
-0.057x | -420.11% |
| 2003-12-31 | CN¥112.11 Million ≈ $16.41 Million |
CN¥-1.23 Million ≈ $-179.74K |
-0.011x | -108.00% |
| 2002-12-31 | CN¥108.87 Million ≈ $15.93 Million |
CN¥14.91 Million ≈ $2.18 Million |
0.137x | +125.90% |
| 2001-12-31 | CN¥161.48 Million ≈ $23.63 Million |
CN¥-85.39 Million ≈ $-12.50 Million |
-0.529x | -1232.97% |
| 2000-12-31 | CN¥207.06 Million ≈ $30.30 Million |
CN¥-8.21 Million ≈ $-1.20 Million |
-0.040x | -157.27% |
| 1999-12-31 | CN¥220.90 Million ≈ $32.33 Million |
CN¥15.30 Million ≈ $2.24 Million |
0.069x | -48.25% |
| 1998-12-31 | CN¥211.44 Million ≈ $30.94 Million |
CN¥28.30 Million ≈ $4.14 Million |
0.134x | -- |
About Berry Genomics Co Ltd
Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcri… Read more